Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,477 | 19,692 | 37,169 | 5,569 | 12,536 |
| TOTAL | $21,508 | $31,897 | $43,793 | $11,031 | $17,944 |
| Non-Current Assets | |||||
| PPE Net | 164 | 205 | 245 | 286 | 327 |
| Investments And Advances | 854 | 465 | 0 | 0 | 0 |
| Other Non-Current Assets | 286 | 316 | 1,074 | 1,200 | 1,462 |
| TOTAL | $1,303 | $985 | $1,319 | $1,487 | $1,789 |
| Total Assets | $22,812 | $32,882 | $45,112 | $12,518 | $19,733 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 904 | 11,549 | 11,185 | 426 | 50 |
| Accounts payable and accrued liabilities | 2,196 | 2,672 | 6,332 | 3,334 | 2,395 |
| Accrued Expenses | 1,726 | 3,492 | 4,497 | 6,338 | 7,757 |
| TOTAL | $6,752 | $19,639 | $23,898 | $12,123 | $15,889 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,886 | N/A | 129 | 10,658 | 904 |
| Other Non-Current Liabilities | 550 | 473 | 405 | 212 | 71 |
| TOTAL | $11,452 | $494 | $563 | $10,870 | $1,018 |
| Total Liabilities | $18,204 | $20,133 | $24,461 | $22,993 | $16,906 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,213 | 8,767 | 8,680 | 8,672 | 6,359 |
| Common Shares | 1,765 | 1,748 | 1,736 | 1,272 | 1,272 |
| Retained earnings | -342,883 | -329,479 | -317,282 | -304,176 | -289,720 |
| TOTAL | $4,607 | $12,749 | $20,651 | $-10,475 | $2,826 |
| Total Liabilities And Equity | $22,811 | $32,882 | $45,112 | $12,518 | $19,733 |